Regulations

FDA Issues Warning Letter to Spa De Soleil, Inc.

Private label company is cited for violations of CGMP regulations.  

Spa De Soleil, Inc. of Sun Valley, CA received a warning letter from the United States Food and Drug Administration (FDA) for violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.

To see the full letter on the FDA website, go here.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters